Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor

被引:122
|
作者
Ishii, S
Nagase, T
Tashiro, F
Ikuta, K
Sato, S
Waga, I
Kume, K
Miyazaki, J
Shimizu, T
机构
[1] UNIV TOKYO,FAC MED,DEPT BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN
[2] UNIV TOKYO,FAC MED,DEPT GERIATR,BUNKYO KU,TOKYO 113,JAPAN
[3] UNIV TOKYO,FAC MED,DEPT DIS RELATED GENE REGULAT RES SANDOZ,BUNKYO KU,TOKYO 113,JAPAN
[4] JAPAN TOBACCO INC,LIFE SCI RES LAB,AOBA KU,YOKOHAMA,KANAGAWA 227,JAPAN
来源
EMBO JOURNAL | 1997年 / 16卷 / 01期
关键词
beta-actin promoter; hyperplasia; lipopolysaccharide; melanocytic tumor; methacholine;
D O I
10.1093/emboj/16.1.133
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although platelet-activating factor (PAF) has been shown to exert pleiotropic effects on isolated cells or tissues, controversy still exists as to whether it plays significant pathophysiological roles in vivo. To answer this question, we established transgenic mice overexpressing a guinea-pig PAF receptor (PAFR). The transgenic mice showed a bronchial hyperreactivity to methacholine and an increased mortality when exposed to bacterial endotoxin. An aberrant melanogenesis and proliferative abnormalities in the skin were also observed in the transgenic mice, some of which spontaneously bore melanocytic tumors in the dermis after aging. Thus, PAFR transgenic mice proved to be a useful model for studying the basic pathophysiology of bronchial asthma and endotoxin-induced death, and screening of therapeutics for these disorders. Furthermore, our findings provide new insights regarding the role of PAF in the morphogenesis of dermal tissues as well as the mitogenic activity of PAF and PAFR in vivo.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 50 条
  • [21] A NOVEL THERAPY FOR GLIOBLASTOMA IN MICE: LAU-0901, A PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST
    Flores, Valerie Cruz
    Menghani, Hemant
    Larissa, K.
    Mukherjee, Pranab
    Belayev, Ludmila
    Bazan, Nicolas
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [22] RELATIONSHIPS BETWEEN TUMOR-NECROSIS-FACTOR, EICOSANOIDS AND PLATELET-ACTIVATING FACTOR AS MEDIATORS OF ENDOTOXIN-INDUCED SHOCK IN MICE
    MYERS, AK
    ROBEY, JW
    PRICE, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (03) : 499 - 502
  • [23] Platelet-Activating Factor Receptor Plays a Role in Lung Injury and Death Caused by Influenza A in Mice
    Garcia, Cristiana C.
    Russo, Remo C.
    Guabiraba, Rodrigo
    Fagundes, Caio T.
    Polidoro, Rafael B.
    Tavares, Luciana P.
    Salgado, Ana Paula C.
    Cassali, Geovanni D.
    Sousa, Lirlandia P.
    Machado, Alexandre V.
    Teixeira, Mauro M.
    PLOS PATHOGENS, 2010, 6 (11)
  • [24] Albuterol Isomers Modulate Platelet-Activating Factor Synthesis and Receptor Signaling in Human Bronchial Smooth Muscle Cells
    Bae, Rena
    Arteaga, Alba
    Raj, J. Usha
    Ibe, Basil O.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2012, 158 (01) : 18 - 26
  • [25] Transgenic mice overexpressing gastrin-releasing peptide receptor in the airway show increased susceptibility to lung tumorigenesis.
    Liu, Xuwan
    Stabile, Laura P.
    Lerner, Edwina C.
    Siegfried, Jill M.
    CANCER RESEARCH, 2006, 66 (08)
  • [26] Platelet-Activating Factor Receptor Blockade Ameliorates Aggregatibacter actinomycetemcomitans-Induced Periodontal Disease in Mice
    Moreira Madeira, Mila Fernandes
    Queiroz-Junior, Celso Martins
    Costa, Graciela Mitre
    Cordeiro Werneck, Silvia Maria
    Cisalpino, Daniel
    Garlet, Gustavo Pompermaier
    Teixeira, Mauro Martins
    Silva, Tarcilia Aparecida
    Souza, Daniele G.
    INFECTION AND IMMUNITY, 2013, 81 (11) : 4244 - 4251
  • [27] Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice
    Rijneveld, AW
    Weijer, S
    Florquin, S
    Speelman, P
    Shimizu, T
    Ishii, S
    van der Poll, T
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (04): : 711 - 716
  • [28] Platelet-activating factor receptor knockout mice are protected from MPTP-induced dopaminergic degeneration
    Kim, Beom Keun
    Shin, Eun-Joo
    Kim, Hyoung-Chun
    Chung, Yoon Hee
    Dang, Duy-Khanh
    Jung, Bae-Dong
    Park, Dae-Hun
    Wie, Myung Bok
    Kim, Won-Ki
    Shimizu, Takao
    Nabeshima, Toshitaka
    Jeong, Ji Hoon
    NEUROCHEMISTRY INTERNATIONAL, 2013, 63 (03) : 121 - 132
  • [29] Effects of Y-24180, a receptor antagonist to platelet-activating factor, on allergic cutaneous eosinophilia in mice
    Yamaguchi, S
    Tomomatsu, N
    Kagoshima, M
    Okumoto, T
    Komatsu, H
    LIFE SCIENCES, 1999, 64 (11) : PL139 - PL144
  • [30] Platelet-activating factor receptor modulates respiratory adaptation to long-term intermittent hypoxia in mice
    Reeves, SR
    Gozal, D
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2004, 287 (02) : R369 - R374